[
  {
    "country":"Belgium",
    "code_name":"Code of Deontology 2025",
    "url":"https:\/\/pharma.be\/sites\/default\/files\/2025-06\/pharma.be_code-of-deontology_eng_def_0.pdf"
  },
  {
    "country":"Belgium",
    "code_name":"Code of Deontology 2024 (FR)",
    "url":"https:\/\/pharma.be\/sites\/default\/files\/2024-06\/20240313_code-voor-deontologie_2024_fr.pdf"
  },
  {
    "country":"Belgium",
    "code_name":"Guidelines on the value of meals offered to HCPs 2021",
    "url":"https:\/\/pharma.be\/sites\/default\/files\/2021-09\/lignes_directrices_valeur_repas.pdf"
  },
  {
    "country":"Bosnia and Herzegovina",
    "code_name":"AIPM BH Code of Practice 2019",
    "url":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2022\/12\/AIPM-BH-Code-of-Practice-2019.pdf"
  },
  {
    "country":"Bosnia and Herzegovina",
    "code_name":"Code of Conduct of Innovative Pharmaceutical Manufacturers",
    "url":"https:\/\/uipl.ba\/wp-content\/uploads\/2023\/06\/UIPL-Kodeks-Code-od-conduct-2023-1.pdf"
  },
  {
    "country":"Brazil",
    "code_name":"Code of Conduct 2021",
    "url":"https:\/\/www.interfarma.org.br\/wp-content\/uploads\/2022\/01\/Codigo-de-conduta_Interfarma_2021_Digital_Ingles_v3-1.pdf"
  },
  {
    "country":"Bulgaria",
    "code_name":"Code of Ethics of the Research-Based Pharmaceutical Industry in Bulgaria Amended 2023",
    "url":"https:\/\/www.arpharm.org\/_files\/ugd\/eb5df2_f5f3ec4cb4be4e83a1a4bc64e6388529.pdf"
  },
  {
    "country":"Canada",
    "code_name":"Code of Ethical Practices",
    "url":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/01\/2022-Code-of-Ethical-Practices-EN-Final.pdf"
  },
  {
    "country":"Chile",
    "code_name":"Codigo de Buenas Practicas",
    "url":"https:\/\/transparencia.cifchile.cl\/downloads\/Codigo%20de%20Buenas%20Practicas%20CIF%202022.pdf"
  },
  {
    "country":"China",
    "code_name":"RDPAC Code of Practice 2022",
    "url":"https:\/\/enadmin.rdpac.org\/upload\/upload_file\/1685425062.pdf"
  },
  {
    "country":"Colombia",
    "code_name":"Codigo de Etica",
    "url":"https:\/\/afidro.org\/wp-content\/uploads\/2022\/08\/Codigo_de_Etica_AFIDRO_2022.pdf"
  },
  {
    "country":"Croatia",
    "code_name":"Code of Conduct",
    "url":"https:\/\/ifi.hr\/wp-content\/uploads\/2023\/03\/IFI-Code-2.pdf"
  },
  {
    "country":"Cyprus",
    "code_name":"Code of Practice",
    "url":"http:\/\/kefea.org.cy\/wp-content\/uploads\/2023\/01\/CY-KEFEA-Code-final-version-15.12.22-English.pdf"
  },
  {
    "country":"Czech Republic",
    "code_name":"aifp eticky kodex",
    "url":"https:\/\/aifp.cz\/file\/3667\/Code%20of%20Practice%20AIFP.pdf"
  },
  {
    "country":"C\u00f4te d'Ivoire (Ivory Coast)",
    "code_name":"LIPA Code of Good Practice 2021",
    "url":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2022\/12\/LIPA-CODE-LAST-VERSION-FEB-2021.pdf"
  },
  {
    "country":"Denmark",
    "code_name":"The Promotion Code",
    "url":"https:\/\/www.enli.dk\/media\/wudd3rrn\/promotion-code-version-50-april-2025.pdf"
  },
  {
    "country":"Denmark",
    "code_name":"The Patient Organisation Code",
    "url":"https://www.enli.dk/media/5gtbbqan/ethical-rules-for-collaboration-between-patient-organisations-version-40-april-2025-clean.pdf"
  },
  {
    "country":"Denmark",
    "code_name":"The Donation Code",
    "url":"https:\/\/www.enli.dk\/media\/50195\/ethical-rules-on-donations-and-grants-version-30-june-2022.pdf"
  },
  {
    "country":"Denmark",
    "code_name":"Lobbying Code (Ethical rules for dialogue and negotiations with decision-makers)",
    "url":"https:\/\/www.enli.dk\/media\/50191\/lobbying-code-june-2022.pdf"
  },
  {
    "country":"Denmark",
    "code_name":"Guide regarding use of digital media",
    "url":"https:\/\/www.enli.dk\/media\/50273\/en-digital-medieguide-version-32.pdf"
  },
  {
    "country":"Denmark",
    "code_name":"Guide regarding International Congresses in Denmark",
    "url":"https:\/\/www.enli.dk\/media\/o2nga2dc\/guide-international-congresses-in-denmark-version-13.pdf"
  },
  {
    "country":"Denmark",
    "code_name":"Guide on Pre-launch",
    "url":"https:\/\/www.enli.dk\/media\/50378\/guideline-regarding-pre-launch-june-2023.pdf"
  },
  {
    "country":"Denmark",
    "code_name":"Guide on Market Research",
    "url":"https:\/\/www.enli.dk\/media\/0tdmxklz\/guidance-on-market-research-clean-april-2025.pdf"
  },
  {
    "country":"Denmark",
    "code_name":"Guide on information material and documentation",
    "url":"https:\/\/www.enli.dk\/media\/2pimiv4k\/guide-on-information-material-and-documentation-eng-september-2024.pdf"
  },
  {
    "country":"Denmark",
    "code_name":"Guidance on reporting activities to ENLI",
    "url":"https:\/\/www.enli.dk\/media\/x4djbnak\/guidance-on-reporting-a-case-to-enlisag-april-2025.pdf"
  },
  {
    "country":"Denmark",
    "code_name":"Guide on financial support and exhibitions",
    "url":"https:\/\/www.enli.dk\/media\/5woj2ogj\/guide-on-financial-support-and-exhibitions-april-2025.pdf"
  },
  {
    "country":"Ecuador",
    "code_name":"Code of Conduct 2019",
    "url":"https:\/\/ifi-promesa.com.ec\/wp-content\/uploads\/2020\/11\/CODIGO-IFI-2019.pdf"
  },
  {
    "country":"Estonia",
    "code_name":"Code of Conduct",
    "url":"https:\/\/rtl.ee\/wp-content\/uploads\/2024\/06\/APME-Ethics-Code-General-Assembly-applicable-from-08.06.2023.pdf"
  },
  {
    "country":"Europe (EFPIA)",
    "code_name":"Code of Practice",
    "url":"https:\/\/www.efpia.eu\/media\/f2ccf3yd\/efpia-code-of-practice-16052025.pdf"
  },
  {
    "country":"Europe (EFPIA)",
    "code_name":"EFPIA Code Report 2024",
    "url":"https:\/\/www.efpia.eu\/media\/rczepk3q\/efpia-code-report-2024.pdf"
  },
  {
    "country":"Europe (EFPIA)",
    "code_name":"Scorecard Meals and Drinks July 2025",
    "url":"https:\/\/www.efpia.eu\/media\/4w2hz2jn\/scorecard-meals-and-drinks-20250707.pdf"
  },
  {
    "country":"Finland",
    "code_name":"Code of Ethics",
    "url":"https:\/\/www.pif.fi\/media\/pharma-industry-finland_code-of-ethics_2023_20240115_v1-2.pdf"
  },
  {
    "country":"France",
    "code_name":"Rules of Professional Conduct 2020 (ENG)",
    "url":"https://www.leem.org/sites/default/files/2022-06/29%2006%2022%20-%20traduction%20anglais%20DDP.pdf"
  },
  {
    "country":"France",
    "code_name":"Rules of Professional Conduct 2025 (FRA)",
    "url":"https://www.leem.org/sites/default/files/2025-07/DDP%202025.pdf"
  },
  {
    "country":"Georgia",
    "code_name":"APCRG ETHIC CODE",
    "url":"https:\/\/drive.google.com\/file\/d\/1lWLstaufbisJniXDjvBfLtlPimX1GOtg\/view"
  },
  {
    "country":"Germany",
    "code_name":"FSA Code for Professionals",
    "url":"https:\/\/www.fsa-pharma.de\/wp-content\/uploads\/2024\/12\/FSA-Kodex-Fachkreise-2024-engl.pdf"
  },
  {
    "country":"Germany",
    "code_name":"FSA Code of Transparency",
    "url":"https:\/\/www.fsa-pharma.de\/wp-content\/uploads\/2024\/12\/FSA-Transparenzkodex-2024-engl.pdf"
  },
  {
    "country":"Germany",
    "code_name":"FSA Code Patient Organizations",
    "url":"https:\/\/www.fsa-pharma.de\/wp-content\/uploads\/2024\/12\/FSA-Kodex-Patientenorganisationen-2024-engl.pdf"
  },
  {
    "country":"Greece",
    "code_name":"Code of Ethics",
    "url":"https:\/\/www.sfee.gr\/wp-content\/uploads\/2024\/06\/CODE-BROCHURE_EN-2024.pdf"
  },
  {
    "country":"Guatemala",
    "code_name":"Code of Good Practices 2020 (ENG)",
    "url":"https://fedefarma.org/wp-content/files_mf/1618243493DIGITALCODEGoodPRACTIVE_FEDEFARMABAJA.pdf"
  },
  {
    "country":"Guatemala",
    "code_name":"Code of Good Practices 2022 (SPA)",
    "url":"https://fedefarma.org/wp-content/files_mf/1682091821FEDEFARMACodigoBuenasPracticasAgosto2022.pdf"
  },
  {
    "country":"Hong Kong",
    "code_name":"Code of Practice",
    "url":"https://www.hkapi.hk/wp-content/uploads/2022/10/21st-edition_HKAPI-Code-of-Practice.pdf"
  },
  {
    "country":"Hungary",
    "code_name":"Code of Practice",
    "url":"https:\/\/aipm.hu\/wp-content\/uploads\/2022\/09\/AIPM_Code_of_Practice_20200526_EN.pdf"
  },
  {
    "country":"IFPMA",
    "code_name":"IFPMA Code of Practice 2019",
    "url":"https:\/\/www.ifpma.org\/wp-content\/uploads\/2018\/09\/2023_IFPMA-Code-Interactive.pdf"
  },
  {
    "country":"Iceland",
    "code_name":"Code of Practice",
    "url":"https://efpia.eu/media/f2ccf3yd/efpia-code-of-practice-16052025.pdf"
  },
  {
    "country":"India",
    "code_name":"OPPI Code of Pharmaceutical Practices",
    "url":"https://www.indiaoppi.com/wp-content/uploads/2019/12/OPPI-Code-of-Pharmaceutical-Practices-2019.pdf"
  },
  {
    "country":"Ireland",
    "code_name":"IPHA Code of Practice for the Pharmaceutical Industry 2021",
    "url":"https:\/\/www.ipha.ie\/wp-content\/uploads\/2025\/03\/IPHA-Code-of-Practice-for-the-Pharmaceutical-Industry-V8.6_14Mar2025.pdf"
  },
  {
    "country":"Ireland",
    "code_name":"IPHA Code of Practice for the Pharmaceutical Industry 2025",
    "url":"https:\/\/www.ipha.ie\/wp-content\/uploads\/2025\/03\/IPHA-Code-of-Practice-for-the-Pharmaceutical-Industry-V8.6_14Mar2025.pdf"
  },
  {
    "country":"Israel",
    "code_name":"The Joint Ethics Covenant",
    "url":"https:\/\/ima-contentfiles.s3.amazonaws.com\/Imaethiccode2024.pdf"
  },
  {
    "country":"Italy",
    "code_name":"Code of Conduct",
    "url":"https:\/\/www.farmindustria.it\/app\/uploads\/2017\/12\/Code-of-Conduct-5.04.2022.pdf"
  },
  {
    "country":"Japan",
    "code_name":"Code of practice",
    "url":"https:\/\/www.jpma.or.jp\/english\/code\/practice\/eki4g60000003js0-att\/code_practice201910.pdf"
  },
  {
    "country":"Kazakhstan",
    "code_name":"Code of Ethics",
    "url":"https:\/\/www.aipm.kz\/images\/article\/news\/2024\/codex-04-2024-en.pdf"
  },
  {
    "country":"Kenya",
    "code_name":"KAPI CODE OF PRACTICE",
    "url":"https:\/\/kapikenya.org\/wp-content\/uploads\/2023\/02\/KAPI-CODE-OF-PRACTICE.pdf"
  },
  {
    "country":"South Korea",
    "code_name":"KRPIA GREEN BOOK III",
    "url":"https:\/\/www.krpia.or.kr\/download?uid=100383&filenum=1"
  },
  {
    "country":"Latvia",
    "code_name":"SIFFA and LPMA Code of Good Practice and Ethics",
    "url":"http:\/\/www.lpma.lv\/wp-content\/uploads\/2022\/12\/KODEKSS_updated-on-01012023_final.docx"
  },
  {
    "country":"Lithuania",
    "code_name":"Code of Ethics 2020",
    "url":"https:\/\/dl.softdent.lt\/vaistukodeksas\/Etikos_KODEKSAS_patvirtintas_EN.pdf"
  },
  {
    "country":"MEA (Middle East and Africa)",
    "code_name":"PHRMAG Code of Promotional Practices 2021",
    "url":"https:\/\/phrmag.com\/wp-content\/uploads\/2023\/10\/MEA-Code-English.pdf"
  },
  {
    "country":"Malaysia",
    "code_name":"Code of Conduct - Prescription",
    "url":"https:\/\/www.phama.org.my\/view_file.cfm?fileid=149"
  },
  {
    "country":"Mexico",
    "code_name":"Code of Integrity 2021",
    "url":"https:\/\/cetifarma.org.mx\/wp-content\/uploads\/docs\/docs\/CIETEMIS-2021eng.pdf"
  },
  {
    "country":"Netherlands",
    "code_name":"Code of Conduct Pharmaceutical Advertising",
    "url":"https:\/\/www.cgr.nl\/CGR.nl\/media\/CGR.nl\/Gedragscode\/20240101-Dutch_CoC_Pharmaceutical_Advertising-ENG-per-20240101.pdf"
  },
  {
    "country":"New Zealand",
    "code_name":"Code of Practice",
    "url":"https:\/\/www.medicinesnz.co.nz\/fileadmin\/user_upload\/Code_of_Practice_Edition_17_published_April_2019_effective_September_2019.pdf"
  },
  {
    "country":"New Zealand",
    "code_name":"Code of Practice 2019 - Supplementary Guidance Note No. 1 2021",
    "url":"https:\/\/www.medicinesnz.co.nz\/fileadmin\/user_upload\/Code_of_Practice_Edition_17_Guidance_Note__Effective_Date_22_April_2021_.pdf"
  },
  {
    "country":"New Zealand",
    "code_name":"Code of Practice 2019 - Supplementary Guidance Note No. 2 2022",
    "url":"https:\/\/www.medicinesnz.co.nz\/fileadmin\/user_upload\/CoP_Edtn_17_Guidance_Note_No._2__Effective_Date_31Mar2022_.pdf"
  },
  {
    "country":"Norway",
    "code_name":"LMI's Industry Rules 2025",
    "url":"https:\/\/www.lmi.no\/download.php?file=\/wp-content\/uploads\/2025\/06\/BRANSJEREGLER-2025_ENG.pdf"
  },
  {
    "country":"Norway",
    "code_name":"LMI's Industry Rules 2025 (NOR)",
    "url":"https:\/\/www.lmi.no\/download.php?file=\/wp-content\/uploads\/2025\/05\/Bransjeregler-2025-1.pdf"
  },
  {
    "country":"Peru",
    "code_name":"Codigo de Etica",
    "url":"https:\/\/alafarpe.org.pe\/wp-content\/uploads\/CODIGO-DE-ETICA_2024.pdf"
  },
  {
    "country":"Philippines",
    "code_name":"PHAP Code of Practice",
    "url":"https://phap.org.ph/pdf/PHAP-PHAP_Code_022425.pdf"
  },
  {
    "country":"Poland",
    "code_name":"Code of Good Practice",
    "url":"https:\/\/en.infarma.pl\/assets\/files\/2021\/The%20Code%20of%20Good%20Practices%202021.pdf"
  },
  {
    "country":"Portugal",
    "code_name":"CODE OF ETHICS",
    "url":"https://codigos.apifarma.pt/files/APIFARMA-CodigoDeontologico-comPR_EN.pdf"
  },
  {
    "country":"Romania",
    "code_name":"ARPIM Code of Ethics 2024",
    "url":"https:\/\/arpim.ro\/wp-content\/uploads\/2024\/06\/PDF-Interactiv_Codul-ARPIM_EN-July-2024.pdf"
  },
  {
    "country":"Russia",
    "code_name":"CODE OF GOOD PRACTICE",
    "url":"https:\/\/lk.aipm.org\/uploads\/eng\/code\/code_of_practice_2025.pdf"
  },
  {
    "country":"Saudi Arabia",
    "code_name":"Code of Pharmaceutical Promotional Practices 2018",
    "url":"https:\/\/www.sfda.gov.sa\/sites\/default\/files\/2024-08\/SFDA422024DEE.pdf"
  },
  {
    "country":"Serbia",
    "code_name":"Inovia kodeks",
    "url":"https:\/\/inovia.rs\/documents\/publications\/2024-inovia-kodeks-eng.pdf"
  },
  {
    "country":"Singapore",
    "code_name":"Code of Conduct",
    "url":"https:\/\/www.sapi.org.sg\/wp-content\/uploads\/2025\/05\/SAPI-Code-2025-1.pdf"
  },
  {
    "country":"Slovakia",
    "code_name":"Code of Conduct",
    "url":"https:\/\/aifp.sk\/upload\/AIFP%20Ethical%20Code%2003.02.2025%20(2).pdf"
  },
  {
    "country":"Slovenia",
    "code_name":"Forum's code of practice 2022",
    "url":"https:\/\/www.farmaforum.si\/en\/about-forum\/codes\/forums-code-of-practice"
  },
  {
    "country":"South Africa",
    "code_name":"The South African Code of Marketing Practice for Health Products Code & Guideline 2025",
    "url":"https:\/\/www.marketingcode.co.za\/wp-content\/uploads\/2025\/05\/MCA-CODE-v18-250523.pdf"
  },
  {
    "country":"Spain",
    "code_name":"Code of Practice 2025",
    "url":"https:\/\/www.codigofarmaindustria.org\/sites\/sarfi\/docs\/PRODF340801.pdf"
  },
  {
    "country":"Sweden",
    "code_name":"ETHICAL RULES FOR THE PHARMACEUTICAL INDUSTRY IN SWEDEN",
    "url":"https:\/\/www.lif.se\/globalassets\/etik\/dokument\/ler-english-version-2022-07-01-mark-up-changes.pdf"
  },
  {
    "country":"Switzerland",
    "code_name":"Code of Conduct 2021",
    "url":"https:\/\/www.scienceindustries.ch\/_file\/27933\/pharmakodex-version-mai-2020-e.pdf"
  },
  {
    "country":"Switzerland",
    "code_name":"Swiss Medtech Code of Ethical Business Practice 2017",
    "url":"https:\/\/www.swiss-medtech.ch\/sites\/default\/files\/2023-05\/Swiss%20Medtech%20Code%20of%20Ethical%20Business%20Practice%20%28Ethics%20Code%29.pdf"
  },
  {
    "country":"Taiwan",
    "code_name":"Code of Practice",
    "url":"http://www.irpma.org.tw/web/upload/20241226105111Rk6kmkM.pdf"
  },
  {
    "country":"Thailand",
    "code_name":"Code of Practice",
    "url":"https:\/\/www.prema.or.th\/wp-content\/uploads\/2023\/05\/CodeofPractice2020.pdf"
  },
  {
    "country":"Turkey",
    "code_name":"AIFD Code of Practice",
    "url":"https:\/\/www.aifd.org.tr\/wp-content\/uploads\/2023\/09\/AIFD-Code-of-Good-Promotional-Practice-20230920.pdf"
  },
  {
    "country":"Ukraine",
    "code_name":"AIPM Code of Conduct 2020",
    "url":"https:\/\/aipm.org.ua\/wp-content\/uploads\/2024\/08\/AIPM-UA-CODE-of-PRACTICE-2020-2.docx"
  },
  {
    "country":"Ukraine",
    "code_name":"IFPMA Code of Practice",
    "url":"https:\/\/aipm.org.ua\/wp-content\/uploads\/2019\/05\/IFPMA_Code_of_Practice_2019.pdf"
  },
  {
    "country":"Ukraine - NEW",
    "code_name":"Code of Ethics 2020 - Revised Feb 2023",
    "url":"http:\/\/aprad.org.ua\/wp-content\/uploads\/2023\/07\/Ukraine-APRAD-Code-of-Ethics-2020_ENG-revised-in-February-2023.pdf"
  },
  {
    "country":"United Kingdom",
    "code_name":"ABPI Code of Practice 2024",
    "url":"https:\/\/www.abpi.org.uk\/media\/xmbnr12q\/final-2024-abpi-code-_interactive.pdf"
  },
  {
    "country":"United Kingdom",
    "code_name":"Code of Practice for the Promotion of Animal Medicines",
    "url":"https://www.noah.co.uk/wp-content/uploads/2022/06/NOAHCode-of-Practice_30-effective-May-2022.pdf"
  },
  {
    "country":"United Kingdom",
    "code_name":"PAGB Consumer Code for Medicines",
    "url":"https://www.pagb.co.uk/content/uploads/2023/08/PAGB-Consumer-Code-Jan-2019.pdf"
  },
  {
    "country":"USA",
    "code_name":"CODE ON INTERACTIONS",
    "url":"https:\/\/www.phrma.org\/-\/media\/Project\/PhRMA\/PhRMA-Org\/PhRMA-Org\/PDF\/P-R\/PhRMA-Code---Final.pdf"
  },
  {
    "country":"USA",
    "code_name":"Principles on Interactions with Patient Organizations",
    "url":"https:\/\/phrma.org\/-\/media\/Project\/PhRMA\/PhRMA-Org\/PhRMA-Org\/PDF\/P-R\/phrma_principles_paper_20120919_final.pdf"
  },
  {
    "country":"Vietnam",
    "code_name":"Code of Business Ethics",
    "url":"https:\/\/vnpca.org.vn\/en\/voluntary-codes-on-business-ethics-in-vietnam-pharmaceutical-biopharmaceutical-sector-2\/"
  }
]